Top

A Novel Early Relapse Prediction Score Based on Age, ISS and Disease Status at the Time of Transplant in Patients with Newly Diagnosed Multiple Myeloma. A Study of the EBMT Chronic Malignancies Working Party

Study type:

Retrospective Studies

Study number:

42206691

Type of treatment:

Autologous

Diseases:

Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)

Short title:

Primary objective:

To develop a scoring system that will enable prediction of of early relapse within 12 months of AHSCT-1 among patients newly diagnosed with Multiple Myeloma

Key inclusion criteria:

Newly diagnosed patients with multiple myeloma having received an AHCT-1 between 2008-2018

Country:

Principal investigator:

Meral Beksac

EBMT Study coordinator:

Linda Koster

Study coordinator email:

cmwpebmt@lumc.nl